Ransomware Intelligence

    Latest Research on INC and The Gentlemen Ransomware: Exposed AI Infrastructure

    Read the Research

    AbelZeta Pharma Ransomware Attack

    abelzeta.comRansomed

    United StatesCountry
    Mar 12, 2026Discovered

    About this victim

    AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.Partners: AstraZeneca, Janssen (J&J), NovartisInvestors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund170,000+ different files670+ separate archives with experiments on various candidates All studies: CAR032, CAR39, CAR66, CAR168, TIL, CD, Tcell, etc. There are a huge number of files and studies, all of which are confidential and valuable for competitive research. https://www.abelzeta.com/

    Domain

    abelzeta.com

    Industry

    Technology

    Country

    United States

    Discovered

    8 months ago

    Confidence

    85%

    Severity

    Medium

    Status

    Claimed

    Threat group

    space bears

    Total victims

    64

    First seen

    Dec 2025

    Last seen

    Oct 2026

    Group status

    active

    Sophistication

    0

    Impact score

    69

    Threat level

    3.7/10
    Aggressiveness5/10
    Lethalityn/a
    Criticality2.2/10

    Status breakdown

    Data Leaked1.6%1
    Claimed
    this victim
    98.4%63

    Victim's position within group

    Industry

    Technology

    Known target sector

    Country

    United States

    Frequently targeted country

    Group activity

    Monthly attacks · space bears

    64

    total · avg 6.4/mo